Cutaneous tissue expressions of matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 are associated with a high degree of disability at diagnosis of hanseniasis

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-4632|54|9|e361-e362

ISSN： 0011-9059

Source： INTERNATIONAL JOURNAL OF DERMATOLOGY, Vol.54, Iss.9, 2015-09, pp. : e361-e362

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tissue Inhibitor of Metalloproteinase-1: Actions beyond Matrix Metalloproteinase Inhibition

By  

Cardiology, Vol. 132, Iss. 3, 2015-0 ,pp. : 147-150

Karger

Access to resources Recommend Favorite

Prognostic Significance of Stromelysin-3 and Tissue Inhibitor of Matrix Metalloproteinase-2 in Esophageal Cancer

By  

Oncology, Vol. 67, Iss. 3-4, 2004-11 ,pp. : 300-309

Karger

Access to resources Recommend Favorite

Fibrogenic and Inflammatory Cytokines Modulate mRNA Expressions of Matrix Metalloproteinase-3 and Tissue Inhibitor of Metalloproteinase-3 in Type II Pneumocytes

By  

Respiration, Vol. 68, Iss. 5, 2001-10 ,pp. : 509-516

Karger

Access to resources Recommend Favorite

Expression of Membrane-Type Matrix Metalloproteinase in Rabbit Neointimal Tissue and Its Correlation with Matrix-Metalloproteinase-2 Activation

By  

Journal of Vascular Research, Vol. 35, Iss. 1, 1998-02 ,pp. : 45-54

Karger

Access to resources Recommend Favorite

Increased adipose tissue expression of lipocalin-2 in obesity is related to inflammation and matrix metalloproteinase-2 and metalloproteinase-9 activities in humans

By Catalán V.  

Journal of Molecular Medicine, Vol. 87, Iss. 8, 2009-08 ,pp. : 803-813

Springer Publishing Company

Access to resources Recommend Favorite